Clincosm LogoSign in Get a demo

multiple sclerosis, chronic progressive

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive Trial in Cleveland (Cionic

Recruiting
  • Multiple Sclerosis
  • +2 more
  • Cionic Neural Sleeve NS-100
  • Actigraph accelerometer
  • Cleveland, Ohio
    Cleveland State University
Jul 25, 2023

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting
  • Multiple Sclerosis (MS)
  • +6 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023

Multiple Sclerosis, Chronic Progressive Trial in United States (NurOwn (MSC-NTF cells))

Completed
Has Results
  • Multiple Sclerosis, Chronic Progressive
  • NurOwn (MSC-NTF cells)
  • Los Angeles, California
  • +3 more
Oct 20, 2022

Multiple Sclerosis, Chronic Progressive, High-Intensity Interval Training, Motor Symptoms Trial in Valens (HIIT, MCT)

Recruiting
  • Multiple Sclerosis, Chronic Progressive
  • +2 more
  • HIIT
  • MCT
  • Valens, Sankt Gallen, Switzerland
    Klinik Valens, Valens rehabilitation clinic
Oct 12, 2022

Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive Trial in Porto Alegre

Not yet recruiting
  • Multiple Sclerosis, Chronic Progressive
  • +3 more
  • Nordic Walking (NWG)
  • +2 more
  • Porto Alegre, Rio Grande Do Sul, Brazil
    Universidade Federal do Rio Grande do Sul
May 17, 2022

Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,

Completed
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis, Primary Progressive
  • Training groupe
  • +3 more
  • Kaposvár, Somogy, Hungary
    Somogy Megyei Kaposi Mór Oktató Kórház
Mar 24, 2022

MS - a Prospective Cohort Study

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
  • PASS-MS
  • Berlin, Germany
    Experimental and Clinical Research Center, Studienambulanz Neuro
Aug 9, 2021

Rotating Frame Relaxation Imaging in Multiple Sclerosis

Completed
  • Multiple Sclerosis
  • +2 more
  • Brain MRI
  • Turku, Finland
    Division of Clinical Neurosciences, Turku University Hospital
Mar 2, 2021

Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Neurorehabilitation,

Completed
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis, Primary Progressive
  • Neurorehabilitation
  • Physiotherapy
  • Kaposvár, Somogy, Hungary
    Somogy Megyei Kaposi Mór Teaching Hospital
Apr 26, 2020

Multiple Sclerosis, Chronic Progressive, Nervous System Diseases Trial in Pau (Rituximab IT, methylprednisolone IV, Rituximab

Completed
  • Multiple Sclerosis, Chronic Progressive
  • Nervous System Diseases
  • Rituximab IT
  • +2 more
  • Pau, France
    Centre hospitalier F. Mitterrand (CH Pau)
Oct 2, 2019

Multiple Sclerosis, Chronic Progressive Trial (Smartphone App)

Unknown status
  • Multiple Sclerosis, Chronic Progressive
  • Smartphone App
  • (no location specified)
May 2, 2017

Multiple Sclerosis, Chronic Progressive Trial in Portland (lipoic acid, Placebo)

Completed
Has Results
  • Multiple Sclerosis, Chronic Progressive
  • lipoic acid
  • Placebo
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Dec 7, 2016

China Betaferon Adherence, Coping and Nurse Support Study

Completed
  • Multiple Sclerosis, Chronic Progressive
  • Interferon beta-1b (Betaseron, BAY86-5046)
  • Many locations, China
    (unnamed)
Sep 2, 2016

Multiple Sclerosis, Chronic Progressive Trial in France (Cyclophosphamide (drug), Methylprednisolone (drug))

Completed
  • Multiple Sclerosis, Chronic Progressive
  • Cyclophosphamide (drug)
  • Methylprednisolone (drug)
  • Bayonne, France
  • +25 more
Mar 14, 2012

Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting Trial in United States (RTL1000 (recombinant T

Unknown status
  • Multiple Sclerosis, Chronic Progressive
  • Multiple Sclerosis, Relapsing-Remitting
  • RTL1000 (recombinant T cell receptor ligand)
  • RTL1000 Placebo
  • New Haven, Connecticut
  • +5 more
Feb 19, 2009

Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive Trial in Ramat Gan (Ritalin)

Unknown status
  • Relapsing Remitting Multiple Sclerosis
  • Multiple Sclerosis, Chronic Progressive
  • Ramat Gan, Israel
    Multiple Sclerosis Center
Jan 4, 2007